NGS in Advanced Cancers
Demographics (2)
- AGE - Age at biopsy (phv00195641.v1.p1)
- SEX - Gender of participant (phv00195642.v1.p1)
Race and Ethnicity (1)
- RACE - Race of participant (phv00195643.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte type (phv00195646.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00195645.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00195635.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00195648.v1.p1)
- IS_TUMOR - Tumor status (phv00195647.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00195649.v1.p1)
- PRIMARY_TUMOR_LOCATI0N - Primary tumor location (phv00195650.v1.p1)
- RESEARCH_TYPE - Type of research subject data was used for (phv00195636.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00195644.v1.p1)
- SAMPLE_ID - Sample ID (phv00195638.v1.p1)
- SAMPLE_USE - Sample use. WES_SRA: Whole exome sequencing data available through SRA; WGS_SRA: Whole genome sequencing data available through SRA; WTS_SRA: Whole transcriptome sequencing (phv00195639.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00195640.v1.p1)
- SUBJECT_ID - Subject ID (phv00195634.v1.p1)
- SUBJECT_ID - Subject ID (phv00195637.v1.p1)